Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
SCHEDULE OF OTHER CURRENT ASSETS

Other current assets consisted of the following as of June 30, 2023 and December 31, 2022:

  

    June 30, 2023     December 31, 2022  
Lab supplies   $ 1,177     $ 1,224  
Prepaid expenses     642       390  
Funds in escrow     500       500  
Other     48       180  
Total other current assets   $ 2,367     $ 2,294  
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

  

    2023     2022     2023     2022  
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2023     2022     2023     2022  
Basic weighted average number of common shares     4,311       4,229       4,309       4,219  
Potential dilutive effect of stock-based awards     5       -       4       -  
                                 
Diluted weighted average number of common shares     4,316       4,229       4,313       4,219  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

   

    2023     2022     2023     2022  
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2023     2022     2023     2022  
Options     475       641       475       641  
Restricted stock units (RSUs)     215       351       217       351  
Warrants     -       63       -       63  
Antidilutive securities excluded from computation of earnings per share     690       1,055       692       1,055